SUSQUEHANNA INTERNATIONAL GROUP, LLP - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 57 filers reported holding PLX PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of PLX PHARMA INC
ValueSharesWeighting
Q1 2023$6,860
-38.0%
52,728
-22.2%
0.00%
Q4 2022$11,056
-76.0%
67,736
-4.3%
0.00%
Q3 2022$46,000
-81.1%
70,764
-29.3%
0.00%
Q2 2022$244,000
-79.4%
100,050
-65.9%
0.00%
Q1 2022$1,184,000
-76.8%
293,050
-54.0%
0.00%
Q4 2021$5,104,000
-56.6%
637,030
+4.5%
0.00%
-100.0%
Q3 2021$11,759,000
+199.4%
609,310
+114.1%
0.00%
Q2 2021$3,928,000
+632.8%
284,592
+266.2%
0.00%
Q4 2017$536,000
-45.7%
77,706
-48.8%
0.00%
Q3 2017$987,000
-30.1%
151,900
-33.9%
0.00%
-100.0%
Q2 2017$1,413,000229,8000.00%
Other shareholders
PLX PHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
MSD Partners, L.P. 1,875,000$4,556,0000.28%
Ground Swell Capital, LLC 48,931$119,0000.22%
Park West Asset Management LLC 1,473,218$3,580,0000.20%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$152,0000.07%
Eidelman Virant Capital 27,000$63,0000.04%
MBL Wealth, LLC 52,000$1260.03%
O'Brien Greene & Co. Inc 22,340$54,0000.02%
SHUFRO ROSE & CO LLC 56,800$138,0000.01%
GW&K Investment Management, LLC 424,921$1,033,0000.01%
EXANE DERIVATIVES 6,575$15,974,0000.01%
View complete list of PLX PHARMA INC shareholders